This announcement contains inside information for the purposes of Article 7 of the UK version of Regulation (EU) No 596/2014 which is part of UK law by virtue of the European Union (Withdrawal) Act 2018, as amended ("MAR"). Upon the publication of this announcement via a Regulatory Information Service, this inside information is now considered to be in the public domain.
26 June 2024
Acuity RM Group plc
("Acuity" or the "Company")
Grant of Options
Acuity (AIM:ACRM), the software group, announces that, on 26 June 2024, the following share options were granted to directors and Persons Discharging Managerial Responsibilities (PDMRs) as detailed below:
| Name | Position | Options granted | Total number of options held |
| Angus Forrest | Executive Chair | 3,002,564 * | 3,802,564 |
| Kerry Chambers | Chief Executive | 2,251,922 | 2,251,922 |
| Kate Buchan | Finance Director | 1,125,961 | 1,125,961 |
| Adam Freeman | Chief Technology Officer | 750,641 | 750,641 |
The options have been granted under the Company's approved Enterprise Management Incentive share option scheme (the "EMI Scheme") and have an exercise price of 3.75 pence per share, the closing mid-market price of the shares, as derived from the AIM Appendix to the London Stock Exchange Daily Official List for 25 June 2024, (being the market price as defined under the rules of the EMI Scheme). Save for 1,501,282 options granted to Angus Forrest, the options are exercisable in whole or in part at any time in the next five years conditional on the market price (under the rules of the EMI Scheme) of the Company's shares reaching double the exercise price for a period of at least five consecutive trading days.
*1,501,282 of the options granted to Angus Forrest have been awarded as a reward for initiating, delivering and successfully integrating the acquisition of Acuity Risk Management Limited. These bonus options are not subject to any performance criteria and are exercisable between the first and tenth anniversaries of the date of grant.
The total number of options granted under the EMI Scheme is 7,131,088, representing approximately 4.75 per cent of the Company's current issued share capital. In addition, there are 1,600,000 unapproved share options. Accordingly, the total number of options that are outstanding is 8,731,088, representing approximately 5.82 per cent of the current issued share capital.
Enquiries:
| Acuity RM Group Plc | www.acuityrmgroup.com | |
| Angus Forrest, Executive Chair | 020 3582 0566 | |
| | | |
| W H Ireland (NOMAD and Broker) | ||
| Mike Coe / Sarah Mather
Clear Capital Limited (Joint Broker) Andrew Blaylock
| 020 7220 1666
020 3869 6080 | |
| Peterhouse Capital Limited (Joint broker) | | |
| Lucy Williams / Duncan Vasey | 020 7469 0936 | |
Note to Editors
Acuity RM Group plc
Acuity RM Group plc (AIM: ACRM), is an established provider of risk management services. Its award-winning STREAM® software platform collects data about organisations to improve business decisions and management. It is used by around 70 organisations in markets including government, utilities, defence, broadcasting, manufacturing and healthcare.
The Company is focused on delivering long term, sustainable growth in shareholder value. In the short to medium term this is expected to come from organic growth and thereafter may also come from complementary acquisitions.
| 1
| Details of the person discharging managerial responsibilities / person closely associated
| |||||
| a)
| Name
| Angus Forrest | ||||
| 2
| Reason for the notification
| |||||
| a)
| Position/status
| Executive Chairman | ||||
| b)
| Initial notification /Amendment
| Initial Notification | ||||
| 3
| Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
| |||||
| a)
| Name
| Acuity RM Group plc | ||||
| b)
| LEI
| 213800JHJFKALDJA5X97 | ||||
| 4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
| |||||
| a)
| Description of the financial instrument, type of instrument
Identification code
|
Share Options over Ordinary shares of 0.1p each
GB00BR0WHY71 | ||||
| b)
| Nature of the transaction
| Grant of Options | ||||
| c)
| Price(s) and volume(s)
|
| ||||
| d)
| Aggregated information
- Aggregated volume
- Price
|
n/a
| ||||
| e)
| Date of the transaction
| 26 June 2024 | ||||
| f)
| Place of the transaction
| Outside of a trading venue | ||||
| 1
| Details of the person discharging managerial responsibilities / person closely associated
| |||||
| a)
| Name
| Kerry Chambers | ||||
| 2
| Reason for the notification
| |||||
| a)
| Position/status
| Chief Executive, Acuity Risk Management Ltd | ||||
| b)
| Initial notification /Amendment
| Initial Notification | ||||
| 3
| Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
| |||||
| a)
| Name
| Acuity RM Group plc | ||||
| b)
| LEI
| 213800JHJFKALDJA5X97 | ||||
| 4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
| |||||
| a)
| Description of the financial instrument, type of instrument
Identification code
|
Share Options over Ordinary shares of 0.1p each
GB00BR0WHY71 | ||||
| b)
| Nature of the transaction
| Grant of Options | ||||
| c)
| Price(s) and volume(s)
|
| ||||
| d)
| Aggregated information
- Aggregated volume
- Price
|
n/a
| ||||
| e)
| Date of the transaction
| 26 June 2024 | ||||
| f)
| Place of the transaction
| Outside of a trading venue | ||||
| 1
| Details of the person discharging managerial responsibilities / person closely associated
| |||||
| a)
| Name
| Kate Buchan | ||||
| 2
| Reason for the notification
| |||||
| a)
| Position/status
| Finance Director | ||||
| b)
| Initial notification /Amendment
| Initial Notification | ||||
| 3
| Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
| |||||
| a)
| Name
| Acuity RM Group plc | ||||
| b)
| LEI
| 213800JHJFKALDJA5X97 | ||||
| 4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
| |||||
| a)
| Description of the financial instrument, type of instrument
Identification code
|
Share Options over Ordinary shares of 0.1p each
GB00BR0WHY71 | ||||
| b)
| Nature of the transaction
| Grant of Options | ||||
| c)
| Price(s) and volume(s)
|
| ||||
| d)
| Aggregated information
- Aggregated volume
- Price
|
n/a
| ||||
| e)
| Date of the transaction
| 26 June 2024 | ||||
| f)
| Place of the transaction
| Outside of a trading venue | ||||
| 1
| Details of the person discharging managerial responsibilities / person closely associated
| |||||
| a)
| Name
| Adam Freeman | ||||
| 2
| Reason for the notification
| |||||
| a)
| Position/status
| Chief Technology Officer, Acuity Risk Management Limited | ||||
| b)
| Initial notification /Amendment
| Initial Notification | ||||
| 3
| Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
| |||||
| a)
| Name
| Acuity RM Group plc | ||||
| b)
| LEI
| 213800JHJFKALDJA5X97 | ||||
| 4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
| |||||
| a)
| Description of the financial instrument, type of instrument
Identification code
|
Share Options over Ordinary shares of 0.1p each
GB00BR0WHY71 | ||||
| b)
| Nature of the transaction
| Grant of Options | ||||
| c)
| Price(s) and volume(s)
|
| ||||
| d)
| Aggregated information
- Aggregated volume
- Price
|
n/a | ||||
| e)
| Date of the transaction
| 26 June 2024 | ||||
| f)
| Place of the transaction
| Outside of a trading venue | ||||
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.